JPRN-UMIN000009539已完成2 期
Phase II study of Pemetrexed and Bevacizumab in Plutinum Unfit patients with untreated advanced non-squamous non-small cell lung cancer(OSAKA-LCSG1201) - OSAKA-LCSG1201
OSAKA-LCSG0 个研究点目标入组 45 人开始时间: 2012年12月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Symptomatic brain metastasis (2) Have another active malignancy (3) Current or previous history of hemoptysis (4) Evidence of tumor invading large vessel on imaging (5) Evidence of tumor invading trachea or main bronchus on imaging (6) Have received radiation therapy to lesions of lung (7) Currently have or have a history of a cardiac effusion which requires treatment (8) Brain infarction within 1 year (9) Problematic infection (10) Scheduled operation (11) Active radiation pneumonitis or esophagitis (13) Pregnant or lactation women, or women with known or suspected pregnancy and men who want let to pregnancy (14) Decision of ineligibility by a physician.
研究者
相似试验
招募中
2 期
Phase II study of Pemetrexed and Bevacizumab in Performance status 2 patients with advanced non-squamous non-small cell lung cancer.JPRN-UMIN000008124iigata Lung Cancer Treatment Group25
已完成
2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000010733Central Japan Lung Study Group37
招募中
2 期
A Phase II study of Pemetrexed/Bevacizumab in patients ineligible for platinum-based chemotherapy with untreated Advanced Non-squamous non-small-cell lung cancer (ALCT003)on-squamous Non-small cell lung cancerJPRN-UMIN000010805Department of Respiratory Medicine Kyorin Univercity Hospital25
招募中
2 期
Phase II Study of Pemetrexed+Bevacizumab for previously untreated elderly patients with nonsquamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000008781Toho university medical center sakura hospital25
尚未招募
2 期
A phase II trial of pemetrexed/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.elderly patients with stage IIIB/IV non-small cell lung cancer except for squamous cell carcinomaJPRN-UMIN000008764Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School36